ABOUT THE PRODUCT
Oncuria is a first-of-its-kind multiplex protein immunoassay being developed to detect, monitor, and predict response to BCG therapy for bladder cancer. It’s a urine-based liquid biopsy that measures 10 validated protein biomarkers.
Information is owner-confirmed
Last updated 0 month ago
Price range